U.S. federal trademark · Serial No. 78139935
Bio-engineered cellular material which is a component of pharmaceutical and therapeutic preparations for use in the treatment of cancer, AIDS, metabolic diseases, neurodegenerative diseases, cardiovascular diseases, hematologic diseases, immune diseases and hormone deficiencies, namely, a packaging cell line that produces retroviral gene therapy vectors; pharmaceutical preparations for use in the treatment of cancer, AIDS, metabolic diseases, neurodegenerative diseases, cardiovascular diseases, and hormone deficiencies, and for packaging cell lines for use in the treatment of cancer, AIDS, metabolic diseases, neurodegenerative diseases, cardiovascular diseases and hormone deficiencies
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.